Histopathology of Transplantable Carcinomas and Sarcomas of the Liver in MiceIngesting Dieldrin or Aldrin

1. Edwards, J. E. , Dalton, A. J. , and Andervont, H. B. : Pathology of transplantable spontaneous hepatoma in a C3H mouse. J. Nat. Cancer Inst. 2:555–563, 1942.

2. Andervont, H. B. , and Dunn, T. B. : Transplantation of spontaneous and induced hepatomas in inbred mice. J. Nat Cancer Inst. 13:455–503, 1952.

3. Leduc, E. H. : Metastasis of transplantable hepatomas from the spleen to the liver in mice. Cancer Res. 19: 1091–1095, 1959.

4. Leduc, E. H. , and Wilson, J. W. : Production of transplantable hepatomas by intrasplenic implantation of normal liver in mouse. J. Nat. Cancer Inst. 30:85–99, 1963.

5. Leduc, E. H. , Malick, L. E. , and Holden, H. E. : Light microscopic observations of transplantable mouse hepatomas. Cancer Res. 34:716–721, 1974.

6. Sato, H. , Belkin, M. , and Essner, E. : Experiments on an ascites hepatoma. III. The conversion of mouse hepatomas into the ascites form. J. Nat. Cancer Inst. 17:1–21, 1956.

7. Andervont, H. B. , and Dunn, T. B. : Transplantation of hepatomas in mice. J. Nat. Cancer Inst. 15:1513–1524, 1955.

8. Leduc, E. H. , and Wilson, J. W. : Transplantation of carbon tetrachloride-induced hepatomas in mice. J. Nat. Cancer Inst. 22:581–591, 1959.

9. Reuber, M. D. : Morphologic and biologic correlation of hyperplastic and neoplastic hepatic lesions occurring “spontaneously” in C3H x Y hybrid mice. Brit. J. Cancer 25:538–543, 1971.

10. Heston, W. E. , and Vlahakis, G. : Influence of the AY gene on mammary gland tumors, hepatomas, and normal growth in mice. J. Nat. Cancer Inst. 26:969–983, 1961.

11. Heston, W. E. : Factors in the causation of spontaneous hepatomas in mice. J. Nat. Cancer Inst. 37:839–843, 1966.

12. Heston, W. E. , Vlahakis, G. , and Deringer, M. K. : High incidence of hepatomas and the increase of this incidence with urethan in C3H, C3Hf, and CeHe male mice. J. Nat. Cancer Inst. 24:425–435, 1966.

13. Vlahakis, G. , and Heston, W. E. : Spontaneous cholangioma in strain C3H Avy fB mice and their hybrids. J. Nat. Cancer Inst. 46:677–683, 1971.

14. Kyriazis, A. P. , and Vesselinovitch, S. D. : Transplantability and biological behaviour of mouse liver tumors. Cancer Res. 33:332–338, 1973.

15. Davis, K. J. , and Fitzhugh, O. G. : Tumorigenic potential of aldrin and dieldrin for mice. Tox. Appl. Pharmacol. 4:187–189, 1962.

16. Davis, K. J.: Pathology report on mice fed aldrin, dieldrin, heptachlor or heptachlor epoxide for two years (prepared as a memorandum to A. J. Lehman, Food and Drug Administration, Washington, D. C., on July 19, 1965).

17. Andervont, H. B.: Personal Communication, 1973.

18. Reuber, M. D. , and Firminger, H. I. : Morphologic and biologic correlation of lesions obtained in hepatic carcinogenesis in A X C rats given 0.025 percent N-2-fluorenyldiacetamide. J. Nat. Cancer Inst. 31:1407–1429, 1963.

19. Reuber, M. D. : Development of preneoplastic and neoplastic lesions of the liver in male rats given 0.025 percent N-2-fluorenyldiacetamide. J. Nat. Cancer Inst. 34:697–724, 1965.

20. Reuber, M. D. : Histopathology of transplantable hepatic carcinomas induced by chemical carcinogens in rats. Gann Monograph 1:43–54, 1966.

21. Reuber, M. D. : Poorly differentiated cholangiocarcinomas occurring “spontaneously” in C3H and C3H x Y hybrid mice. J. Nat. Cancer Inst. 38:901–907, 1967.

22. Walker, A. I. T. , Thorpe, E. , and Stevenson, D. E. : The toxicology of dieldrin (HEOD). 1. Long-term toxicity studies in mice. Fd. Cosmet. Toxicol. 11:415–432, 1972.

23. Thorpe, E. , and Walker, A. I. T. : The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, α-BHC, and β-BHC. Fd. Cosmet. Toxicol. 11:433–442, 1973.

24. Thorpe, E.: Transplantation of hepatomas in mice given dieldrin (unpublished data).

25. Trainin, N. : Neoplastic nature of liver “blood cysts” induced by urethane in mice. J. Nat. Cancer Inst. 31: 1489–1499, 1963.

26. Edwards, J. E. , Andervont, H. B. , and Dalton, A. : A transplantable malignant hemangioendothelioma of the liver in the mouse. J. Nat. Cancer Inst. 2:479–490, 1942.

27. Akamatsu, Y. , Wada, F. , and Ikegami, R. : Transplantation of spontaneous hepatomas in C3H mice: Biological and biochemical studies. Gann 60:145–150, 1969.

28. Nash, R. E. , and Llanos, J. M. : Twenty-four-hour variations in DNA synthesis of a fast-growing and slow-growing hepatoma. J. Nat. Cancer Inst. 47:1007, 1971.

29. Head, M. A. , and Laird, H. M. : A histological study of the latent period of hepatoma grafts. Brit. J. Cancer 15: 615–623, 1961.

30. Albert, A. , and Ortowsky, M. : Some peculiar biological and biochemical properties of a mouse hepatoma induced by chrysoidin. I. Biological and biochemical characteristics of the hepatoma. J. Nat. Cancer Inst. 25: 443–453, 1960.

31. Szacki, J. , Lawinski, M. , and Grzebieluch, M. : Growth of transplantable chrysoidin hepatoma after splenectomy in mice. Archivum Immunologiae et Therapiae Exper. 20:333, 1972.

32. Prejean, J. D. , Griswold, D. P. , and Weisburger, J. H. : Transplantation of allogenic tumors in rats and mice treated with azathioprine, prednisone, and anti-lymphocyte serum. Proc. Soc. Exper. Biol. Med. 139:1425–1428, 1972.

33. Trotter, N. A. : The effect of partial hepatectomy on subcutaneous transplanted hepatoma in mice. Cancer Res. 21:778–782, 1961.